Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis

K19 capsular polysaccharide of Acinetobacter baumannii is produced via a Wzy polymerase encoded in a small genomic island rather than the KL19 capsule gene cluster

(2016) Johanna J. Kenyon et al.   MICROBIOLOGY-SGM

Cryopreservation of virulent Acinetobacter baumannii to reduce variability of in vivo studies

(2015) Travis B. Nielsen et al.   BMC MICROBIOLOGY

The structure of the polysaccharide isolated from Acinetobacter baumannii strain LAC-4

(2014) Evgeny Vinogradov et al.   CARBOHYDRATE RESEARCH

Immunization against Multidrug-Resistant Acinetobacter baumannii Effectively Protects Mice in both Pneumonia and Sepsis Models

(2014) Weiwei Huang et al.   PLoS One

A multifunctional bispecific antibody protects against Pseudomonas aeruginosa

(2014) A. DiGiandomenico et al.   Science Translational Medicine

The FDA Reboot of Antibiotic Development

(2013) David M. Shlaes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The K1 Capsular Polysaccharide from Acinetobacter baumannii Is a Potential Therapeutic Target via Passive Immunization

(2013) Thomas A. Russo et al.   INFECTION AND IMMUNITY

The value of single-pathogen antibacterial agents

(2013) Brad Spellberg et al.   NATURE REVIEWS DRUG DISCOVERY

Variation in the Complex Carbohydrate Biosynthesis Loci of Acinetobacter baumannii Genomes

(2013) Johanna J. Kenyon et al.   PLoS One

The capsular polysaccharide and lipopolysaccharide structures of two carbapenem resistant Klebsiella pneumoniae outbreak isolates

(2012) Joanna Kubler-Kielb et al.   CARBOHYDRATE RESEARCH

Macrophage Killing of Bacterial and Fungal Pathogens Is Not Inhibited by Intense Intracellular Accumulation of the Lipoglycopeptide Antibiotic Oritavancin

(2012) Beverlie Baquir et al.   CLINICAL INFECTIOUS DISEASES

White Paper: Recommendations on the Conduct of Superiority and Organism-Specific Clinical Trials of Antibacterial Agents for the Treatment of Infections Caused by Drug-Resistant Bacterial Pathogens

(2012)   CLINICAL INFECTIOUS DISEASES

Active and Passive Immunization Protects against Lethal, Extreme Drug Resistant-Acinetobacter baumannii Infection

(2012) Guanpingshen Luo et al.   PLoS One

Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes

(2012) Lin Lin et al.   VACCINE

Inhibition of LpxC Protects Mice from Resistant Acinetobacter baumannii by Modulating Inflammation and Enhancing Phagocytosis

(2012) L. Lin et al.   mBio

Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii

(2011) Michael J. McConnell et al.   VACCINE

Clinical Outcomes of Carbapenem-Resistant Acinetobacter baumannii Bloodstream Infections: Study of a 2-State Monoclonal Outbreak

(2010) L. Silvia Munoz-Price et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine

(2010) Michael J. McConnell et al.   VACCINE

Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia

(2009) Gokhan Metan et al.   European Journal of Internal Medicine

Evaluation of Flagella and Flagellin of Pseudomonas aeruginosa as Vaccines

(2009) V. L. Campodonico et al.   INFECTION AND IMMUNITY

A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline

(2009) N. C. Gordon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Global spread of carbapenem-resistant Acinetobacter baumannii

(2009) P. G. Higgins et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Use of an Anti-CD40 Agonist Monoclonal Antibody During Immunizations Enhances Hybridoma Generation

(2008) Michael A. Rycyzyn et al.   HYBRIDOMA

The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America

(2007) B. Spellberg et al.   CLINICAL INFECTIOUS DISEASES